|
CHD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.161010E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.134800E-01 |
| Normal-vs-Stage2 |
5.520000E-01 |
| Normal-vs-Stage3 |
6.939200E-01 |
| Normal-vs-Stage4 |
1.832000E-01 |
| Stage1-vs-Stage2 |
8.849400E-01 |
| Stage1-vs-Stage3 |
2.439400E-01 |
| Stage1-vs-Stage4 |
2.587900E-02 |
| Stage2-vs-Stage3 |
4.317800E-01 |
| Stage2-vs-Stage4 |
1.950180E-01 |
| Stage3-vs-Stage4 |
4.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.184390E-01 |
| Normal-vs-AfricanAmerican |
9.411000E-01 |
| Normal-vs-Asian |
3.797000E-01 |
| Caucasian-vs-AfricanAmerican |
1.321820E-01 |
| Caucasian-vs-Asian |
3.605800E-01 |
| AfricanAmerican-vs-Asian |
4.712800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.016600E-01 |
| Normal-vs-Female |
1.547690E-02 |
| Male-vs-Female |
4.013900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.627400E-01 |
| Normal-vs-Extreme_Weight |
8.894800E-01 |
| Normal-vs-Obese |
8.827900E-02 |
| Normal-vs-Extreme_Obese |
6.705800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.651600E-01 |
| Normal_Weight-vs-Obese |
2.026000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.977400E-01 |
| Extreme_Weight-vs-Obese |
1.522020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.425000E-01 |
| Obese-vs-Extreme_Obese |
2.489600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.858200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.306400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.966400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.884000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.006200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.221400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.740490E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.394000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.315700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.464000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.393870E-02 |
| Normal-VS-Type2 PRCC |
2.246400E-02 |
| Normal-VS-KIRP CIMP |
3.340400E-01 |
| Normal-VS-Unclassified PRCC |
1.117440E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.98709999460678E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.265600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.286600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.688500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.483000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.924000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.656590E-01 |
| Normal-vs-N1 |
2.103600E-01 |
| Normal-vs-N2 |
2.043600E-01 |
| N0-vs-N1 |
1.835620E-02 |
| N0-vs-N2 |
6.788800E-01 |
| N1-vs-N2 |
1.603040E-01 |
|
|
